| Original language | English (US) |
|---|---|
| Pages (from-to) | 2917-2923 |
| Number of pages | 7 |
| Journal | Blood Advances |
| Volume | 7 |
| Issue number | 12 |
| DOIs | |
| State | Published - Jun 1 2023 |
ASJC Scopus subject areas
- Hematology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Blood Advances, Vol. 7, No. 12, 01.06.2023, p. 2917-2923.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - BH3 profiling identifies BCL-2 dependence in adult patients with early T-cell progenitor acute lymphoblastic leukemia
AU - Olesinski, Elyse A.
AU - Bhatia, Karanpreet S.
AU - Mahesh, Aarthi N.
AU - Rosli, Shazwina
AU - Mohamed, Jameelah S.
AU - Jen, Wei Y.
AU - Jain, Nitin
AU - Garcia, Jacqueline S.
AU - Wong, Gee C.
AU - Ooi, Melissa
AU - Letai, Anthony
AU - Konopleva, Marina
AU - Bhatt, Shruti
N1 - Funding Information: The authors thank all patients and families who consented to providing samples for this study at the Dana-Farber Cancer Institute, MD Anderson Cancer Center, National University Hospital Singapore, and Singapore General Hospital. The authors thank Triona Ni Chonghaile, Royal College of Surgeons in Ireland, for providing the editorial assistance. S.B. is a recipient of the Leukemia and Lymphoma Society Career Development Fellow Award. S.B. acknowledges support from the American Society of Hematology Global Research Award, NCIS and NUS Cancer Program Seed funding grant, and the National Medical Research Council of Singapore under award number OFIRG21NOV-0062. M.K. was supported by R01CA241191. J.S.G. was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award number K08CA245209, NIH/NCI SPORE in Myeloid Malignancies Grant Number 1P50CA206963, and the Ted and Eileen Pasquarello Tissue Bank in Hematologic Malignancies. A.L. acknowledges Funding Information: Acknowledgments: The authors thank all patients and families who consented to providing samples for this study at the Dana-Farber Cancer Institute, MD Anderson Cancer Center, National University Hospital Singapore, and Singapore General Hospital. The authors thank Triona Ni Chonghaile, Royal College of Surgeons in Ireland, for providing the editorial assistance. S.B. is a recipient of the Leukemia and Lymphoma Society Career Development Fellow Award. S.B. acknowledges support from the American Society of Hematology Global Research Award, NCIS and NUS Cancer Program Seed funding grant, and the National Medical Research Council of Singapore under award number OFIRG21NOV-0062. M.K. was supported by R01CA241191. J.S.G. was supported by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) under award number K08CA245209, NIH/NCI SPORE in Myeloid Malignancies Grant Number 1P50CA206963, and the Ted and Eileen Pasquarello Tissue Bank in Hematologic Malignancies. A.L. acknowledges Funding Information: support from the NIH under award number P01CA066996. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or NCI.
PY - 2023/6/1
Y1 - 2023/6/1
UR - http://www.scopus.com/inward/record.url?scp=85164658377&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85164658377&partnerID=8YFLogxK
U2 - 10.1182/bloodadvances.2022007728
DO - 10.1182/bloodadvances.2022007728
M3 - Letter
C2 - 36763538
AN - SCOPUS:85164658377
SN - 2473-9529
VL - 7
SP - 2917
EP - 2923
JO - Blood Advances
JF - Blood Advances
IS - 12
ER -